The main focus of the book “Advances in CNS Demyelinating Disorders”, is to provide a comprehensive understanding of the management principles across the spectrum of CNS demyelinating disorders such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disease (MOGAD), and other seronegative entities. Each chapter delves into the multifaceted nature of these disorders, highlighting advances in research and clinical care while acknowledging the challenges that persist in their management.
This book is intended for clinicians and students who are striving to better understand and manage CNS demyelinating disorders. While significant progress has been made in improving outcomes for patients, much work remains to be done, particularly in areas of individualized treatment and long-term care strategies.This book provides a comprehensive review of the latest research and clinical practices in the management of central nervous system (CNS) demyelinating disorders, including multiple sclerosis, neuromyelitis optica, myelin oligodendrocyte glycoprotein disorders, and seronegative CNS demyelinating disorders. It is designed for clinicians and students seeking to expand their understanding of these disorders. Each chapter examines the therapeutic approaches and highlights practical perspectives on dealing with CNS demyelinating disorders. It underscores the importance of personalized treatment plans and emphasizes the need for ongoing research to improve outcomes for those affected by these conditions.
